These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 31537382)

  • 41. Dutasteride, the dual 5alpha-reductase inhibitor, inhibits androgen action and promotes cell death in the LNCaP prostate cancer cell line.
    Lazier CB; Thomas LN; Douglas RC; Vessey JP; Rittmaster RS
    Prostate; 2004 Feb; 58(2):130-44. PubMed ID: 14716738
    [TBL] [Abstract][Full Text] [Related]  

  • 42. 11-Ketotestosterone and 11-Ketodihydrotestosterone in Castration Resistant Prostate Cancer: Potent Androgens Which Can No Longer Be Ignored.
    Pretorius E; Africander DJ; Vlok M; Perkins MS; Quanson J; Storbeck KH
    PLoS One; 2016; 11(7):e0159867. PubMed ID: 27442248
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Androgens stimulate fatty acid synthase in the human prostate cancer cell line LNCaP.
    Swinnen JV; Esquenet M; Goossens K; Heyns W; Verhoeven G
    Cancer Res; 1997 Mar; 57(6):1086-90. PubMed ID: 9067276
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Androgenic biomarker prof|ling in human matrices and cell culture samples using high throughput, electrospray tandem mass spectrometry.
    Wilton JH; Titus MA; Efstathiou E; Fetterly GJ; Mohler JL
    Prostate; 2014 May; 74(7):722-31. PubMed ID: 24847527
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of 5-alpha-reductase inhibition and dexamethasone administration on the growth characteristics and intratumor androgen levels of the human prostate cancer cell line PC-3.
    Tuttle RM; Loop S; Jones RE; Meikle AW; Ostenson RC; Plymate SR
    Prostate; 1994 May; 24(5):229-36. PubMed ID: 8170835
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Steroid-growth factor interaction in human prostate cancer. 2. Effects of transforming growth factors on androgen metabolism of prostate cancer cells.
    Carruba G; Granata OM; Farruggio R; Cannella S; Bue AL; Leake RE; Pavone-Macaluso M; Castagnetta LA
    Steroids; 1996 Jan; 61(1):41-6. PubMed ID: 8789735
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Long-term exposure of tumor necrosis factor alpha causes hypersensitivity to androgen and anti-androgen withdrawal phenomenon in LNCaP prostate cancer cells.
    Harada S; Keller ET; Fujimoto N; Koshida K; Namiki M; Matsumoto T; Mizokami A
    Prostate; 2001 Mar; 46(4):319-26. PubMed ID: 11241555
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Differential androgen sensitivity is associated with clonal heterogeneity in steroid metabolism, ornithine decarboxylase regulation and IL-1alpha action in mouse mammary tumor cells.
    Hida N; Poulin R; Veilleux R; Labrie F
    J Steroid Biochem Mol Biol; 1999 Nov; 71(1-2):71-81. PubMed ID: 10619359
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Serum-free complete medium, an alternative medium to mimic androgen deprivation in human prostate cancer cell line models.
    Fiandalo MV; Wilton JH; Mantione KM; Wrzosek C; Attwood KM; Wu Y; Mohler JL
    Prostate; 2018 Feb; 78(3):213-221. PubMed ID: 29194687
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Androgen formation and metabolism in the pulmonary epithelial cell line A549: expression of 17beta-hydroxysteroid dehydrogenase type 5 and 3alpha-hydroxysteroid dehydrogenase type 3.
    Provost PR; Blomquist CH; Godin C; Huang XF; Flamand N; Luu-The V; Nadeau D; Tremblay Y
    Endocrinology; 2000 Aug; 141(8):2786-94. PubMed ID: 10919264
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Enrichment of putative prostate cancer stem cells after androgen deprivation: upregulation of pluripotency transactivators concurs with resistance to androgen deprivation in LNCaP cell lines.
    Seiler D; Zheng J; Liu G; Wang S; Yamashiro J; Reiter RE; Huang J; Zeng G
    Prostate; 2013 Sep; 73(13):1378-90. PubMed ID: 23728788
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Advantages of total androgen blockade in the treatment of advanced prostate cancer.
    Geller J; Albert J; Vik A
    Semin Oncol; 1988 Apr; 15(2 Suppl 1):53-61. PubMed ID: 3285484
    [TBL] [Abstract][Full Text] [Related]  

  • 53. 5alpha-androstane-3alpha,17beta-diol supports human prostate cancer cell survival and proliferation through androgen receptor-independent signaling pathways: implication of androgen-independent prostate cancer progression.
    Yang Q; Titus MA; Fung KM; Lin HK
    J Cell Biochem; 2008 Aug; 104(5):1612-24. PubMed ID: 18320593
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Androgen deprivation therapy in combination with radiotherapy for high-risk clinically localized prostate cancer.
    Nishiyama T
    J Steroid Biochem Mol Biol; 2012 Apr; 129(3-5):179-90. PubMed ID: 22269996
    [TBL] [Abstract][Full Text] [Related]  

  • 55. P450-dependent enzymes as targets for prostate cancer therapy.
    De Coster R; Wouters W; Bruynseels J
    J Steroid Biochem Mol Biol; 1996 Jan; 56(1-6 Spec No):133-43. PubMed ID: 8603034
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Interactions between vitamin D and androgen receptor signaling in prostate cancer cells.
    Weigel NL
    Nutr Rev; 2007 Aug; 65(8 Pt 2):S116-7. PubMed ID: 17867385
    [No Abstract]   [Full Text] [Related]  

  • 57. Inefficient UGT-conjugation of adrenal 11β-hydroxyandrostenedione metabolites highlights C11-oxy C
    du Toit T; Swart AC
    Mol Cell Endocrinol; 2018 Feb; 461():265-276. PubMed ID: 28939401
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Rapid androgen actions on calcium signaling in rat sertoli cells and two human prostatic cell lines: similar biphasic responses between 1 picomolar and 100 nanomolar concentrations.
    Lyng FM; Jones GR; Rommerts FF
    Biol Reprod; 2000 Sep; 63(3):736-47. PubMed ID: 10952915
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Androgen glucuronides analysis by liquid chromatography tandem-mass spectrometry: could it raise new perspectives in the diagnostic field of hormone-dependent malignancies?
    Kalogera E; Pistos C; Provatopoulou X; Athanaselis S; Spiliopoulou C; Gounaris A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Dec; 940():24-34. PubMed ID: 24140653
    [TBL] [Abstract][Full Text] [Related]  

  • 60. 11β-Hydroxydihydrotestosterone and 11-ketodihydrotestosterone, novel C19 steroids with androgenic activity: a putative role in castration resistant prostate cancer?
    Storbeck KH; Bloem LM; Africander D; Schloms L; Swart P; Swart AC
    Mol Cell Endocrinol; 2013 Sep; 377(1-2):135-46. PubMed ID: 23856005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.